PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding PharmaCyte Biotech, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 24 | 30 | +6 |
| Shares | 1.40M | 3.47M | +2.08M (+148.7%) |
| Value | $4.42M | $8.68M | +$4.25M (+96.2%) |
New holders (11)
Institutions that held PharmaCyte Biotech, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 613,666 | $1.53M | 0.00% |
| Equitec Proprietary Markets, LLC | 258,694 | $647.0K | 0.34% |
| Anson Funds Management LP | 193,400 | $484.0K | 0.07% |
| Ayrton Capital LLC | 153,130 | $383.0K | 0.36% |
| Northern Trust Corp | 35,456 | $89.0K | 0.00% |
| Marshall Wace, LLP | 13,515 | $35.0K | 0.00% |
| Jump Financial, LLC | 10,300 | $26.0K | 0.00% |
| Blue Bell Private Wealth Management, LLC | 2 | $0 | 0.00% |
| CWM, LLC | 1 | $0 | 0.00% |
| Carolina Wealth Advisors, LLC | 2 | $0 | 0.00% |
| Comprehensive Financial Consultants Institutional, Inc. | 14 | $0 | 0.00% |
Sold out (5)
Institutions that held PharmaCyte Biotech, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| NorthRock Partners, LLC | 37,164 | $118.0K |
| FMR LLC | 500 | $2.00K |
| Harbour Investments, Inc. | 3 | $0 |
| Cutler Group LP | 78 | $0 |
| Charter Oak Capital Management, LLC | 20 | $0 |